Amphastar Pharmaceuticals Inc.

AMPH | NDAQ

Overview

Corporate Details

ISIN(s):: US03209R1032 (+3 more)
LEI:: 54930055TH0ZLSAQMJ38
Country:: United States of America
Address:: 850 NEW BURTON ROAD, 19904 DOVER
Website:: https://amphastar.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Amphastar Pharmaceuticals Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
2025-09-03 00:00	Investor Presentation Wells Fargo Healthcare Presentation	English	3.0 MB

Automate Your Workflow. Get a real-time feed of all Amphastar Pharmaceuticals Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Amphastar Pharmaceuticals Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
4BASEBIO PLC Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.	United Kingdom	4BB
ABINGDON HEALTH PLC A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.	United Kingdom	ABDX
ABIONYX Pharma Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.	France	ABNX
AB Science Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.	France	AB
AcuCort AB Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.	Sweden	ACUC
Advicenne Develops and commercializes therapies for rare renal diseases for patients of all ages.	France	ALDVI
AegirBio AB Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.	Sweden	AEGIR
Aelis Farma Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.	France	AELIS
AGRONOMICS LIMITED	Isle of Man	ANIC
ALK-Abelló Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.	Denmark	ALK